Iain M. Cockburn
Iain M. Cockburn
Questrom School of Business, Boston University
Verified email at bu.edu - Homepage
Title
Cited by
Cited by
Year
Measuring competence? Exploring firm effects in pharmaceutical research
R Henderson, I Cockburn
Strategic management journal 15 (S1), 63-84, 2006
40482006
Scale, scope and spillovers: the determinants of research productivity in drug discovery
R Henderson, I Cockburn
RAND Journal of Economics 27 (1), 32-59, 1996
1857*1996
Absorptive capacity, coauthoring behavior, and the organization of research in drug discovery
IM Cockburn, RM Henderson
The journal of industrial Economics 46 (2), 157-182, 1998
17421998
Industry Effects and Appropriability Measures in the Stock Market's Valuation of R&D and Patents
I Cockburn, Z Griliches
The American Economic Review 78 (2), 419-423, 1988
9331988
Gone but not forgotten: knowledge flows, labor mobility, and enduring social relationships
A Agrawal, I Cockburn, J McHale
Journal of Economic Geography 6 (5), 571-591, 2006
923*2006
Untangling the origins of competitive advantage
I Cockburn, R Henderson, S Stern
Strategic Management Journal 21 (10-11), 112-1145, 2000
9182000
The economics of reproducibility in preclinical research
LP Freedman, IM Cockburn, TS Simcoe
PLoS Biol 13 (6), e1002165, 2015
6862015
Opportunity costs and entrepreneurial activity
R Amit, E Muller, I Cockburn
Journal of business venturing 10 (2), 95-106, 1995
4971995
The anchor tenant hypothesis: exploring the role of large, local, R&D-intensive firms in regional innovation systems
A Agrawal, I Cockburn
International journal of industrial organization 21 (9), 1227-1253, 2003
4792003
Information technology and intangible output: The impact of IT investment on innovation productivity
L Kleis, P Chwelos, RV Ramirez, I Cockburn
Information Systems Research 23 (1), 42-59, 2012
3962012
Characteristics of demand for pharmaceutical products: an examination of four cephalosporins
SF Ellison, I Cockburn, Z Griliches, J Hausman
The RAND journal of Economics, 426-446, 1997
3171997
New pills for poor people? Empirical evidence after GATT
JO Lanjouw, IM Cockburn
World Development 29 (2), 265-289, 2001
313*2001
Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research
IM Cockburn, RM Henderson
Journal of health economics 20 (6), 1033-1057, 2001
2882001
Racing to invest? The dynamics of competition in ethical drug discovery
I Cockburn, R Henderson
Journal of Economics & Management Strategy 3 (3), 481-519, 1994
2611994
Are all patent examiners equal? Examiners, patent characteristics, and litigation outcomes
I Cockburn, S Kortum, S Stern
Patents in the knowledge-based economy, 17-53, 2003
258*2003
Generics and New Goods in Pharmaceutical Price Indexes
Z Griliches, I Cockburn
The American Economic Review 84 (5), 1213-1232, 1994
2511994
Mixed Poisson regression models with covariate dependent rates
P Wang, ML Puterman, I Cockburn, N Le
Biometrics, 381-400, 1996
2441996
The changing structure of the pharmaceutical industry
IM Cockburn
Health Affairs 23 (1), 10-22, 2004
2422004
Patents and the survival of Internet-related IPOs
S Wagner, I Cockburn
Research Policy 39 (2), 214-228, 2010
220*2010
Patents, thickets and the financing of early‐stage firms: evidence from the software industry
IM Cockburn, MJ MacGarvie
Journal of Economics & Management Strategy 18 (3), 729-773, 2009
2062009
The system can't perform the operation now. Try again later.
Articles 1–20